80
Participants
Start Date
March 30, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
September 1, 2026
Cofrogliptin+SGLT2i+Metformin
The cofrogliptin add-on group will continue their existing SGLT2i plus metformin regimen and dosing, with the add-on of cofrogliptin over 24 weeks of triple combined therapy.
Metformin dose escalation
The metformin dose escalation group will have their metformin dose gradually increased to the target dose.
RECRUITING
Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou
Ningbo Medical Center Lihuili Hospital
OTHER_GOV
Hangzhou Traditional Chinese Medicine Hospital
UNKNOWN
Wenzhou Central Hospital
OTHER
The Second Affiliated Hospital of Dalian Medical University
OTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER